SW医药生物行业跑输同期沪深300指数。2025年3月28日-2025年4月10日,SW医药生物行业下跌5.20%,跑输同期沪深300指数约0.18个百分点。SW医药生物行业三级细分板块中,多数细分板块均录得负收益,其中血液制品和线下药店板块涨幅居前,分别上涨7.36%和1.41%;医疗研发外包和体外诊断板块跌幅居前,分别下跌21.38%和10.62%。行业新闻。4月9日起,全国中成药采购联盟集中...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.